Holen Sie sich die Stockscreener-App
1.625
0.31%
-0.005
Handel nachbörslich:
1.62
-0.005
-0.31%
Schlusskurs vom Vortag:
$1.63
Offen:
$1.61
24-Stunden-Volumen:
61,067
Relative Volume:
0.18
Marktkapitalisierung:
$42.75M
Einnahmen:
$4.99M
Nettoeinkommen (Verlust:
$-28.29M
KGV:
-1.5435
EPS:
-1.0528
Netto-Cashflow:
$-36.20M
1W Leistung:
+0.93%
1M Leistung:
+1.56%
6M Leistung:
+26.95%
1J Leistung:
-8.19%
1-Tages-Spanne:
$1.60
$1.63
1-Wochen-Bereich:
$1.58
$1.64
52-Wochen-Spanne:
$0.8502
$2.00
Lava Therapeutics Nv Stock (LVTX) Company Profile
Firmenname
Lava Therapeutics Nv
Sektor
Branche
Telefon
31 6 3000 3035
Adresse
YALELAAN 62, UTRECHT
Vergleichen Sie LVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.625 | 42.88M | 4.99M | -28.29M | -36.20M | -1.0528 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-04-19 | Eingeleitet | Jefferies | Buy |
| 2021-04-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Lava Therapeutics Nv Aktie (LVTX) Neueste Nachrichten
How analysts revise price targets for LAVA Therapeutics N.V. (4PKB) stockQuarterly Portfolio Report & Daily Profit Focused Screening - newser.com
Will LAVA Therapeutics N.V. stock benefit from green energy trendsExit Point & Entry Point Confirmation Signals - newser.com
How to track smart money flows in LAVA Therapeutics N.V.2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Can LAVA Therapeutics N.V. hit a new high this monthTrade Analysis Summary & Technical Confirmation Trade Alerts - newser.com
How LAVA Therapeutics N.V. stock valuations compare to rivalsJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Ranking LAVA Therapeutics N.V. among high performing stocks via toolsTrade Exit Report & Community Consensus Picks - newser.com
Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsTrade Entry Report & Reliable Price Breakout Signals - newser.com
Why hedge funds are buying LAVA Therapeutics N.V. stockJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com
Heatmap analysis for LAVA Therapeutics N.V. and competitorsJuly 2025 Closing Moves & Community Verified Trade Signals - newser.com
What indicators show strength in LAVA Therapeutics N.V.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Is LAVA Therapeutics N.V. showing signs of accumulationJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Reversal indicators forming on LAVA Therapeutics N.V. stock2025 Volatility Report & Weekly High Return Opportunities - newser.com
Custom strategy builders for tracking LAVA Therapeutics N.V.Swing Trade & Daily Price Action Insights - newser.com
Analyzing LAVA Therapeutics N.V. with risk reward ratio chartsTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Market Growth Report & Stepwise Trade Signal Implementation - newser.com
Historical volatility pattern of LAVA Therapeutics N.V. visualizedWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Price momentum metrics for LAVA Therapeutics N.V. explained2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-31 00:32:41 - newser.com
What analysts say about LAVA Therapeutics NV 4PKB stockInsider Trading Activity & Low Cost Portfolio Tips - earlytimes.in
Finanzdaten der Lava Therapeutics Nv-Aktie (LVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lava Therapeutics Nv-Aktie (LVTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 16 '25 |
Sale |
1.49 |
690,239 |
1,028,456 |
4,128,912 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 14 '25 |
Sale |
1.51 |
227,341 |
343,285 |
5,019,151 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 13 '25 |
Sale |
1.54 |
47,686 |
73,436 |
5,246,492 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 10 '25 |
Sale |
1.55 |
49,869 |
77,297 |
5,294,178 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 09 '25 |
Sale |
1.56 |
48,169 |
75,144 |
5,344,047 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 08 '25 |
Sale |
1.57 |
28,954 |
45,458 |
5,392,216 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 19 '25 |
Sale |
1.40 |
2,370,533 |
3,322,065 |
0 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 19 '25 |
Sale |
1.40 |
532,870 |
746,764 |
0 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 17 '25 |
Sale |
1.49 |
362,806 |
540,291 |
2,736,644 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 18 '25 |
Sale |
1.44 |
366,111 |
527,859 |
2,370,533 |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):